Ocean Biomedical Inc.
OCEA
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.4M
Close$
$-0.05
25050% downside
Current Fair Value
25050% downsideOvervalued by 25050% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.40 Million |
|---|---|
| Enterprise Value | $29.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | -0.33 |
| Outstanding Shares | 27,502,537 |
Return
| Return on Equity | 26.56% |
|---|---|
| Return on Assets | -1551.20% |
| Return on Invested Capital | 10.17% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.71 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | -0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-1.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-1.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 47.54% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.92%▼ 13.92% |
|---|---|
| Total Invested | $5,693▼ 97.70% |
| Investors Holding | 4▼ 19.00% |
ESG Score
No data
About Ocean Biomedical Inc.
2 employees